The critical need to include India in global infectious disease trials

Venu Gopal Jonnalagadda

doi:10.4103/apjtm.apjtm_353_25

Asian Pacific Journal of Tropical Medicine ›› 2025, Vol. 18 ›› Issue (12) :569 -570. DOI: 10.4103/apjtm.apjtm_353_25

Letter to Editor

research-article

The critical need to include India in global infectious disease trials

Venu Gopal Jonnalagadda

Author information +

History +

PDF (190KB)

Cite this article

Download citation ▾

Venu Gopal Jonnalagadda. The critical need to include India in global infectious disease trials. Asian Pacific Journal of Tropical Medicine, 2025, 18 (12) : 569-570 DOI:10.4103/apjtm.apjtm_353_25

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Manoharan K, Jinson J, Ramesh K, George M. Clinical trial trends over the last 5 years among the BRICS (Brazil, Russia, India, China, and South Africa) nations. Perspect Clin Res 2024; 15: 128-133.

[2]	Liu Q, Jing W, Liu M, Liu J. Health disparity and mortality trends of infectious diseases in BRICS from 1990 to 2019. J Glob Health 2022; 12: 04028.

[3]	Konwar M, Maurya MR, Nishandar TB, Thatte UM, Gogtay NJ. An evaluation of drug lag for new drugs approved by the Indian regulator relative to the United States, European Union, and Japanese regulatory agencies: A 15-year analysis (2004-2018). Perspect Clin Res 2021; 12: 159-164.

[4]	National University of Singapore. ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID) dated 22 November 2022. [Online]. Available from: https://sph.nus.edu.sg/2022/11/advancing-clinical-evidence-in-infectious-diseases-advance-id/. [Accessed on 11 July 2024].